When Captain Bahig Saliba, a seasoned American Airlines pilot with more than 27 years of service, refused a COVID‑19 vaccine, he found himself confronting not only corporate policy but the federal regulatory framework.

In 2022, Saliba filed a civil action in the U.S. District Court for the District of Arizona, alleging that American Airlines and the Federal Aviation Administration (FAA) retaliated against him for his vaccine refusal. The suit, pending before the Ninth Circuit (Case No. 23‑15249), contends that the airline demanded a fitness‑for‑duty examination without a legitimate basis and that the FAA’s medical certification process was weaponized to coerce pilots into vaccination.

Central to Saliba’s complaint is the FAA’s handling of the emergency‑use‑authorization (EUA) for COVID‑19 vaccines. He argues that the agency’s Federal Air Surgeon, Dr. Susan Northrup, granted EUA status for the vaccines immediately after FDA approval, bypassing the usual 12‑month waiting period that applies after a drug receives full FDA approval. According to Saliba, this action exceeded the FAA’s statutory authority, which he says is limited to aviation safety and does not extend to public health objectives such as herd immunity.

The FAA’s medical certification is codified in Title 18 of the United States Code. Dr. Northrup describes the process as a legal requirement for pilots to disclose any health condition that could impair flight safety. Saliba contends that forcing a vaccine creates a coerced declaration that undermines the integrity of the certification system. He cites reports of rare but serious side effects—blood clotting and heart complications—that could render a pilot grounded if they were compelled to receive the vaccine.

In addition to the lawsuit against the airline, Saliba lodged a safety complaint with the FAA in late 2023. The complaint alleged that the agency pressured pilots to use the Johnson & Johnson vaccine between April 19, 2021 and December 23, 2022, after the FDA had suspended the vaccine for clotting concerns. Saliba says the FAA’s Office of Audit and Evaluation opened an investigation but that Dr. Northrup shelved it. He subsequently filed a mandamus suit (Case No. 25‑3884) in the Ninth Circuit, seeking to compel the FAA to complete the investigation.

Saliba’s case sits amid broader pandemic‑era tensions over vaccine mandates in aviation. The FAA’s role in approving medical certifications for pilots and air traffic controllers placed it at the heart of the debate, and his lawsuit questions whether the agency’s rapid EUA approvals were consistent with its statutory mandate.

As of the latest filings, the Ninth Circuit has not yet ruled on the merits of Saliba’s claims. The FAA has not issued a public statement in response to the lawsuit, and American Airlines has not released an official comment. The case remains pending, with the next scheduled hearing set for early 2025.

The outcome could reshape how the FAA regulates medical certifications and how airlines enforce vaccine policies. If a court finds that the FAA exceeded its authority, it could trigger a review of the agency’s EUA approvals and prompt changes in how medical mandates are applied to pilots and other aviation personnel.

For now, the legal dispute continues to unfold, with both parties awaiting the court’s decision on whether the FAA’s actions were lawful and whether the airline’s demands constituted retaliation.